Description

2-(4-Benzyl-Piperidin-1-Yl)-9-Methyl-4-Oxo-4H-Pyrido[1,2-A]Pyrimidine-3-Carbaldehyde is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, offering a key building block for the synthesis of novel therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new active pharmaceutical ingredients (APIs) and bioactive molecules.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of novel drug candidates, particularly in central nervous system (CNS) and oncology research.
• Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies to optimize potency and selectivity of target molecules.
• API Development: Employed in the development and scale-up processes for new Active Pharmaceutical Ingredients (APIs).
• Biochemical Tool Compound: Acts as a research tool in biochemical assays and pharmacological studies to investigate specific biological pathways.
• Fine Chemical Synthesis: Utilized in multi-step organic synthesis for creating complex, high-value specialty chemicals.
• Contract Research & Manufacturing (CRAM): Supplied to organizations providing custom synthesis and process development services.

Basic Information

Product Name	2-(4-Benzyl-Piperidin-1-Yl)-9-Methyl-4-Oxo-4H-Pyrido[1,2-A]Pyrimidine-3-Carbaldehyde
CAS No.	885952-11-4
Molecular Formula	C22H23N3O2
Molecular Weight	361.44 g/mol
Synonyms	9-Methyl-2-[4-(phenylmethyl)-1-piperidinyl]-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carboxaldehyde; 2-(4-Benzylpiperidin-1-yl)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbaldehyde; Pyrido[1,2-a]pyrimidine-3-carbaldehyde, 2-(4-benzyl-1-piperidinyl)-9-methyl-4-oxo-; CAS 885952-11-4
EINECS	Contact for details

Quality Control

Our production of 2-(4-Benzyl-Piperidin-1-Yl)-9-Methyl-4-Oxo-4H-Pyrido[1,2-A]Pyrimidine-3-Carbaldehyde adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. All material is characterized and released according to in-house specifications developed for advanced pharmaceutical intermediates. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment to support your regulatory and R&D documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its sensitivity, the material should be stored under an inert atmosphere (e.g., nitrogen or argon) to prevent oxidation. Keep the container tightly sealed in a dry environment to minimize exposure to moisture.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Any single unknown impurity	≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.